This case simulation—grounded in patterns observed across hundreds of clinical consultations—is designed to support evidence-informed interpretation of the Neural Zoomer Sample Report.
A 41-year-old male presents with a recent six-week onset of cognitive and neuropsychiatric symptoms. Previously healthy and highly active, he reports a sudden decline in cognitive performance that is now affecting both his work and daily functioning.
Key concerns include:
Relevant history includes:
Notably, the patient recalls developing a painful cold sore approximately 2–3 weeks before the onset of neurological symptoms. The lesion resolved spontaneously and was initially dismissed as insignificant. However, when reviewing the timeline of events, he recognized that the viral episode preceded the onset of his cognitive decline.
Prior evaluation by his primary care physician revealed positive thyroid peroxidase and thyroglobulin antibodies, with normal TSH, free T4, and free T3 levels.
Medications prescribed for anxiety, insomnia, and psychiatric symptoms had provided little benefit at the time of Neural Zoomer testing.
The most striking finding was markedly elevated antibodies against NMDA receptors.
NMDA receptors play a role in learning, memory formation, synaptic plasticity, and cognitive processing.
In established immune-mediated NMDA receptor disorders, patients may develop symptoms that closely resemble psychiatric illness, including:
Notably, the patient's primary complaints of brain fog, impaired concentration, forgetfulness, word-finding difficulties, and emotional changes closely mirror the neurological functions governed by NMDA receptor signaling.
Several markers pointed toward microglial activation and immune reactivity towards blood brain barrier-associated proteins
Anti-Microglia IgG+IgA: 19.1 — high moderate
Anti-S100B IgG+IgA: 16.5 — moderately elevated
Anti-Glial Fibrillary Acidic Protein (GFAP) IgG+IgA: 13.4 — moderately elevated
Why This Matters
The blood-brain barrier (BBB) functions as a highly selective protective interface between the bloodstream and the central nervous system.
When BBB integrity becomes compromised:
Elevated serum anti-GFAP and anti-S100B autoantibodies may reflect prior immune exposure to brain-derived proteins, potentially through BBB disruption or other mechanisms.
Clinical Pearl
Blood-brain barrier dysfunction frequently serves as an amplifier of neurological symptoms by allowing peripheral immune activation to influence central nervous system function.
The patient had elevated antibodies against tubulin.
Tubulin is a structural protein involved in neuronal architecture axonal transport, neural signaling, and maintenance of nerve cell integrity
Immune reactivity against tubulin has been reported in association with:
While other major myelin markers remained within reference range, the elevated anti-tubulin finding may represent an early signal of neural tissue immune reactivity.
This finding becomes particularly noteworthy given:
Although Neural Zoomer is not a diagnostic tool for demyelinating disease, these results suggest that immune-mediated reactivity to neural tissues warrant further evaluation.
One of the most clinically compelling aspects of this case is the temporal relationship between viral symptoms and neurological decline.
Clinical Timeline
Elevated Viral Markers
Herpes Simplex Virus Type 1 (HSV-1)
Epstein-Barr Virus (EBV)
Why This Matters
HSV-1 is a neurotropic virus capable of establishing lifelong latency within nervous system tissue. Additionally, HSV-1 infection is a confirmed trigger of post-viral anti-NMDA encephalitis.
Likewise, EBV has been implicated in multiple neurological and autoimmune conditions, including multiple sclerosis.
The patient's recent cold sore provides a plausible clinical trigger for immune activation.
While Neural Zoomer does not diagnose active infection, the combination of recent HSV-1 symptoms, elevated HSV-1 and EBV antibodies, neuroinflammation markers, and neurological symptoms raises the possibility that viral reactivation contributed to the patient's immune and neurological presentation.
Clinical Pearl
In patients presenting with acute-onset neurological symptoms, consider exploring recent viral infections or reactivations as potential initiating events.
The patient also had elevated antibodies to Aquaporin-4.
Aquaporin-4 (AQP4) is a water-channel protein found throughout the brain, spinal cord, and optic nerves.
AQP4 plays an important role in:
The concurrent elevation of AQP4, GFAP, and S100B antibodies suggests a broader pattern of immune reactivity directed at astrocyte-associated proteins.
Given this patient's presentation and Neural Zoomer findings, clinicians may consider additional evaluation of:
This case highlights how rapidly developing cognitive and neuropsychiatric symptoms can arise in the context of neuroimmune dysfunction.
Key findings included:
Taken together, the findings suggest a pattern of neuroinflammation, microglial activation, humoral immune reactivity towards blood-brain barrier proteins, and possible infection-triggered immune activation that closely aligns with the patient's abrupt onset of cognitive and neurological symptoms.
The Neural Zoomer provides clinicians with a broader view of immune reactivity affecting the nervous system, helping identify patterns that may otherwise remain overlooked when neurological symptoms are attributed solely to stress, anxiety, or psychiatric causes.